<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f6";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(7.5 0 0 7.5 37.7953 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">440</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 37.7953 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.677 0.847 1.161 1.499 1.985 2.323 2.682 3.204 3.705 4.225 4.922 5.444 5.966 6.488 6.989" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">Ultrarresúmenes </svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 118.523 787.491) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.235" x="0 1.062 2.149" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)">DAE</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 151.402 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.35 0.865 1.351 1.689 2.175 2.525 2.695 3.181 3.531 4.046 4.405 4.927 5.442 5.928 6.266 6.752 7.186 7.368 7.885 8.407 8.757 9.262 9.784 10.134 10.651 11.166 11.683 12.184 12.366 12.8 12.982 13.499 14.021 14.543" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)"> para la preparación de oposiciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 756.7928) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.833 1.333 1.833 2.111 2.611 3.111 3.555 3.777 4.055 4.555 4.888 5.388 5.888 6.388 6.888 7.166 7.444 7.944 8.444 8.888 9.11 9.61 10.11 10.332 10.832 11.11 11.332 11.776 12.054 12.554 13.054 13.387 13.887 14.609 15.109 15.331 15.831 16.331 16.553 17.164 17.664 18.164 18.442 18.886 19.386" font-family="g_d0_f4" font-size="1px" fill="rgb(61,68,70)">Medidas terapéuticas en el síndrome de Addison</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 734.838199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 734.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.561 1.005 1.283 1.727 2.005 2.394 2.838 3.282 3.671 3.893 4.337 4.781 5.225 5.614 5.836 6.28 6.724 6.946 7.224 7.668 7.946 8.613 9.057 9.446 9.89 10.112 10.556 11 11.222 11.611 12.055 12.444 12.666 12.888 13.332 13.554 13.998 14.276 14.72 14.942 15.22 15.442 15.831 16.275 16.497 16.941 17.385 17.607 17.996 18.44 18.884 19.106 19.55 19.772 19.994 20.438 20.882 21.104 21.548 21.77 22.214 22.658 22.88 23.324 23.768 24.046 24.49 24.879 25.101 25.545 25.767 26.156 26.378 26.822 27.266 27.71 28.154 28.598 29.042 29.486 29.764 30.208 30.597 30.819 31.041 31.263 31.707 32.151 32.373 32.817 33.261 33.65" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Intervenciones no farmacológicas: dieta rica en sodio, baja en potasio y abundantes líquidos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 723.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 723.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.561 1.005 1.283 1.727 2.005 2.394 2.838 3.282 3.671 3.893 4.337 4.781 5.225 5.614 5.836 6.114 6.558 6.836 7.503 7.947 8.336 8.78 9.002 9.446 9.89 10.112 10.501 10.945 11.334 11.556 11.778 12.222 12.444 12.888 13.277 13.721 14.11 14.554 14.832 15.11 15.332 15.721 16.165 16.387 16.831 17.275 17.664 17.886 18.275 18.497 19.164 19.386 19.83 20.274 20.552 20.996 21.218 21.662 22.051 22.495 22.773 23.051 23.273 23.662 24.106 24.328 24.772 25.216 25.605" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Intervenciones farmacológicas: glucocorticoides y mineralocorticoides.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 701.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.833 1.333 1.833 2.111 2.611 3.111 3.555 3.777 4.055 4.555 4.888 5.388 5.888 6.388 6.888 7.166 7.444 7.944 8.444 8.888 9.11 9.61 10.11 10.332 10.61 11.11 11.332 11.832 12.165 12.443 12.887 13.165 13.609 13.831 14.331 14.831 15.331 15.609 16.053 16.553 17.053 17.331 17.831 18.331" font-family="g_d0_f4" font-size="1px" fill="rgb(61,68,70)">Medidas terapéuticas en la crisis addisoniana</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 679.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 679.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.7279 0.9499 1.3939 1.8379 2.0599 2.5039 2.9479 3.3369 3.5588 3.7808 4.2248 4.5028 4.7808 5.2248 5.6138 6.0578 6.5018 6.9458 7.3348 7.7788 8.1678" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Líquidos intravenosos:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 668.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.5009 1.7229 2.1669 2.5559 2.9999 3.3889 3.8329 4.0549 4.2769 4.7209" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Glucosalina</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 657.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.3889 1.6109 2.0549 2.4439 3.1109 3.5549" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Plasma.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 635.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 635.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 1.172 1.45 2.117 2.561 2.95 3.394 3.783 4.005 4.227 4.671 4.893 5.337 5.615 6.059 6.448 6.892 7.17 7.448 7.67 8.059 8.503 8.947 9.391 9.613 10.002 10.224 10.613 11.057 11.446 11.89 12.334 12.612 13.056 13.445 13.889 14.167 14.611 15" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Fármacos: hidrocortisona y vasopresores.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 624.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 624.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.173 1.451 1.895 2.284 2.506 2.728 3.172 3.616 3.894 4.116 4.56 4.782 5.226 5.504 5.726 6.115 6.559 6.948 7.17 7.559 7.781 8.225 8.614 8.836 9.28 9.724 10.168 10.612" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Otros: antibióticos y oxígeno.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.727 2.005 2.283 2.727 2.949 3.393 3.782 4.004 4.448 4.892 5.114 5.336 5.78 6.002 6.446 6.835 7.113 7.391 7.835 8.057 8.279 8.557 9.001 9.39 9.612 9.834 10.278 10.5 10.944 11.333 11.611 11.889 12.333 12.722 13.166 13.444 13.888 14.11 14.554 14.998 15.276 15.72 16.387 16.831 17.053 17.275 17.719 17.941 18.385 18.774 19.218 19.885 20.107 20.551 20.94 21.162 21.551 21.773 22.217 22.661 22.939 23.383 24.05 24.494 24.772 25.05 25.494 25.883 26.105 26.549 26.993 27.66 28.104 28.548 28.77 29.214 29.658 30.325 30.547 30.936 31.38 31.769" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Controles de: electrolitos, electrocardiograma, glucemias y parámetros hemodinámicos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 591.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.536 1.092 1.703 2.203 2.592 3.203 4.147 4.758 5.258 5.536 5.869 6.48 7.424" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">Feocromocitoma</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 569.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 569.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3393 0.7093 1.1533 1.8203 2.2643 2.5423 2.7956 3.2396 3.6836 4.1276 4.5716 5.0156 5.4596 5.9036 6.1569 6.6009 7.0449 7.2982 7.6872 8.1312 8.3532 8.7972 9.0192 9.4632 9.8522 10.1055 10.4945 10.7725 11.2165 11.8835 12.3275 12.5495 12.7718 13.2158 13.6598 14.0488 14.3021 14.5241 15.1911 15.6351 16.0791 16.5231 16.7451 17.1891 17.4424 17.8314 18.2754 18.7194 18.9974 19.4414 19.7194 19.9974 20.4414 20.8854 21.3294 21.5514 21.7734 22.0267 22.4707 22.9147 23.3587 23.612 23.834 24.056 24.5 24.944 25.222 25.666 25.9193 26.3083 26.7523 27.1963 27.4743 27.6963 28.1403 28.5843 29.0283 29.4723 29.8613 30.1146 30.5586 30.9476 31.3366 31.7806 32.1696 32.3916 32.7806 33.2246 33.6136 33.8669 34.3109 34.7549 35.0082 35.3972 35.8412 36.1192 36.5632 36.9522 37.3962 37.6182 38.0622 38.7292 38.9512 39.3952 39.8392 40.2282 40.4815 40.7035 41.1475 41.5915 41.8695 42.3135 42.7575 43.2015 43.4235 43.6455 44.0895 44.5335 44.7868 45.2308 45.4841 45.9281 46.3721 46.5941 47.0381 47.4821" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Tumor pequeño de células cromaﬁ nes (médula suprarrenal) que libera cantidades excesivas de catecolaminas (adrenalina o epinef</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 491.964297 569.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.5 0.944 1.388 1.6413 2.0303" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">rina y </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196914 558.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.166 1.61 2.054 2.332 2.776 3.22 3.664 3.886 4.108 4.552 4.996 5.218 5.662 5.884 6.328 6.772 7.05 7.494 7.938 8.16 8.604 9.048 9.326 9.604 9.826 10.27 10.714 10.936" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">noradrenalina o norepinefrina).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 547.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 547.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.783 2.061 2.505 2.894 3.338 3.782 4.004 4.226 4.67 5.059 5.281 5.725 6.169 6.613 7.002 7.224 7.668 8.112 8.334 8.556 9 9.278 9.722 10 10.444 10.666 11.11 11.499 11.721 12.11 12.554 12.776 12.998 13.276 13.72 13.998 14.22 14.664 15.053 15.275 15.942 16.386 16.775 16.997 17.386 17.83 18.497 18.941 19.385 19.829 20.218 20.44 20.884 21.328 21.55 21.994 22.216 22.438 22.66 23.104 23.548 23.992 24.214 24.658 25.102 25.38 25.824 26.213 26.657 27.101 27.323" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Aparecen lesiones unilaterales solitarias más comunes en el lado derecho. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 536.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 536.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.061 1.505 1.949 2.393 3.06 3.282 3.726 4.17 4.392 4.836 5.28 5.558 5.836 6.28 6.502 6.724 7.168 7.557 7.779 8.223 8.667 8.889 9.278 9.5 9.944 10.388 10.61 11.054 11.498 11.942 12.331 12.553 12.775 13.164 13.386 13.775 14.219 14.441 14.885 15.329 15.551 15.995 16.439 16.717 16.939 17.161 17.605 18.049 18.493 18.715 18.937 19.381 19.825 20.047 20.491 21.158 21.602 22.046 22.435 22.657 23.046 23.49 23.879 24.323 24.712" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Predomina entre los 25 y 50 años, y se da por igual en ambos sexos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 525.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 525.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.005 1.227 1.671 2.06 2.449 2.893 3.282 3.726 3.948 4.392 4.836 5.058 5.28 5.724 6.113 6.335 6.724 7.168 7.446 7.89 8.279 8.723 8.945 9.389 10.056 10.278 10.722 11.166 11.555 11.777 12.221 12.61 12.888 13.11 13.777 14.221 14.443 14.887 15.109 15.331 15.775 16.164 16.386 16.664 17.108 17.497 17.941 18.385 18.663 19.107 19.385 19.829 20.218 20.44 20.884 21.106 21.384 21.828 22.05 22.439 22.661 23.105 23.549 23.827 24.271 24.493 24.937 25.381 25.659 26.103 26.547 26.991 27.269 27.713 27.935 28.324 28.768 29.157 29.379" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> El exceso de las catecolaminas estimula los receptores alfa y beta adrenérgicos: </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 514.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.778 2.056 2.278 2.945 3.389 3.611 4.055 4.444 4.666 5.11 5.554 5.776 6.22 6.664 6.886 7.164 7.608 7.997 8.441 8.885 9.163 9.607 9.885 10.329 10.718 10.94 11.384 11.606 11.884 12.328" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Estimulación de receptores alfa:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.7008 503.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(111,113,117)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.1547 503.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.284 1.562 1.784 2.173 2.617 3.006 3.228 3.672 4.116 4.338 4.782 5.226 5.448 5.67 6.114 6.503 6.725 7.169 7.391 7.835 8.279 8.723 9.167 9.389 9.833 10.222 10.444 10.833 11.277 11.721 12.165 12.443 12.665 13.109 13.553 13.831 14.275 14.664" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Activación de las glándulas sudoríparas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.7008 492.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(111,113,117)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.1547 492.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.561 1.005 1.449 1.671 2.115 2.337 2.726 2.948 3.392 3.836 4.058 4.502 4.946 5.168 5.39 5.834 6.056 6.445 6.889 7.278 7.556 8 8.389 8.611 9.055 9.499 9.721 10.165 10.609 10.831 11.053 11.497 11.886 12.33 12.552 12.774 13.218 13.662" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Inhibición de la secreción de insulina.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.7008 481.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(111,113,117)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.1547 481.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.117 1.506 2.173 2.395 2.839 3.283 3.672 3.894 4.338 4.782 5.004 5.448 5.892 6.114 6.336 6.558 6.78 7.224 7.446 7.89 8.112 8.501 8.945 9.389 9.833 10.277 10.499 10.943 11.387 11.831 12.053 12.275 12.719 12.997 13.441 13.83 14.108 14.33 14.774 15.218 15.44" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Disminución del ﬂ ujo sanguíneo intestinal.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1966 459.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.778 2.056 2.278 2.945 3.389 3.611 4.055 4.444 4.666 5.11 5.554 5.776 6.22 6.664 6.886 7.164 7.608 7.997 8.441 8.885 9.163 9.607 9.885 10.329 10.718 10.94 11.384 11.828 12.106 12.55" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Estimulación de receptores beta:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.7008 448.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(111,113,117)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.1547 448.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.709 1.153 1.597 2.041 2.263 2.652 3.096 3.374 3.818 4.04 4.484 4.706 4.928 5.317 5.761 6.15 6.594 7.038 7.26 7.482 7.926 8.204 8.648 9.037 9.259 9.703 10.147 10.369 10.591 11.035 11.313 11.757 12.201 12.59 13.034 13.478 13.7 13.922 14.366 14.644 15.088 15.477 15.699 16.143 16.587 16.809 17.198 17.42 17.864 18.308 18.975 19.419 19.863 20.141 20.585 20.807 21.251 21.695 21.917 22.139 22.583 22.805 23.194 23.638 24.082 24.36 24.638 25.082 25.471 25.749 25.971 26.193 26.415 26.859 27.303 27.747 27.969 28.636 28.858 29.302 29.691 30.135 30.413 30.857 31.079 31.468 31.912" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Taquicardia, vasodilatación, broncodilatación y aumento de la contractilidad miocárdica.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.7008 437.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(111,113,117)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.1547 437.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.117 1.561 1.95 2.394 2.838 3.282 3.726 4.17 4.392 4.614 5.003 5.225 5.614 5.836 6.225 6.447 6.836 7.28 7.669 7.947 8.391 8.78 9.002 9.446 9.89 10.112 10.556 11 11.222 11.666 12.055 12.277 12.721 13.165 13.554 13.776 14.22 14.498 14.942 15.331 15.775 16.164 16.386 16.608 16.83 17.274 17.552 17.996 18.385" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Glucogenolisis y secreción de ácidos grasos libres.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 415.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.5 1 1.5 2 2.278 2.778 3.278 3.722 3.944 4.388 4.61 5.332 5.832 6.332 6.61 7.11 7.554 7.776 8.276 8.776 8.998 9.498 9.776 10.276 10.776 11.276 11.776 12.22 12.498 12.776 13.276" font-family="g_d0_f4" font-size="1px" fill="rgb(61,68,70)">Técnicas y medios de diagnóstico</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 393.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 393.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.061 1.505 1.949 2.393 2.837 3.226 3.448 3.892 4.336 4.558 4.78 5.224 5.668 6.112 6.39 6.834 7.112 7.556 7.834 8.056 8.5 8.722 8.944 9.388 9.832 10.499 10.943 11.387 11.665 12.109 12.331 12.775 13.219 13.441 13.663 14.107 14.496 14.718 15.107 15.551 15.995 16.384 16.828 17.272 17.55 17.828 18.272 18.661 18.883 19.327 19.771 20.215 20.604 20.826 21.27 21.492 21.936 22.325 22.992 23.436 23.714 23.936 24.325 24.769 25.158 25.38 25.824 26.268 26.49 26.879 27.323 27.601 28.045 28.434 28.878 29.1 29.544 30.211 30.433 30.877 31.321 31.71" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Pruebas de laboratorio: aumento de las concentraciones plasmáticas de catecolaminas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 382.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 382.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.172 1.45 1.894 2.338 2.56 3.004 3.393 3.615 4.059 4.503 4.725 4.947 5.614 6.058 6.502 6.946 7.39 7.612 8.056 8.5 8.778 9.222 9.444 9.666 10.11 10.499 10.943 11.165 11.387 11.72 12.164 12.442 12.664 13.108 13.33 13.552 13.83 14.274 14.718 15.107 15.385 15.829 16.496 16.94 17.329 17.551 17.829 18.273 18.94 19.384" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Estudios de imagen para localizar el feocromocitoma.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 371.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 371.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.061 1.505 1.949 2.393 2.837 3.059 3.503 3.947 4.169 4.558 5.002 5.446 5.724 6.168 6.557 6.779 7.223 7.667 7.889 8.278 8.722 9.166 9.388 9.777 9.999 10.443 10.887 11.109 11.553 11.775 12.219 12.663" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Prueba de supresión con clonidina:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 360.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2 2.389 2.611 3.055 3.499 3.721 4.165 4.387 4.831 5.275 5.497 5.941 6.33 6.552 6.996 7.44 7.662 8.106 8.55 8.828 9.05 9.494 9.938 10.216 10.66 11.104 11.548 11.826 12.27 12.492 12.881 13.325 13.547 13.991 14.435 14.657 15.101 15.49 15.879 16.101 16.545 16.989 17.211 17.6 18.044 18.488 18.766 19.044 19.488 19.71 19.932 20.376 20.82 21.264 21.486 21.875 22.319 22.763 23.041 23.263 23.93 24.374 24.596 24.818 25.262 25.484 25.706 25.928 26.372 26.816 27.094 27.538 27.927 28.149 28.593 29.037 29.259 29.703 30.147 30.369 30.758 31.202 31.48 31.924 32.313 32.757 32.979 33.423 34.09 34.312 34.756 35.2 35.589 35.811 36.255 36.699 36.921 37.588 38.032 38.476 38.698 39.142 39.531 39.753 40.197 40.641 40.863 41.307 41.751 42.195 42.473 42.917 43.361 43.805 44.249 44.693 44.915" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- La clonidina es un antiadrenérgico de acción central que suprime la liberación de catecolaminas de mediación neurógena. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 349.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.293 0.945 1.404 1.863 2.076 2.535 2.772 2.985 3.278 3.737 4.196 4.6 4.893 5.352 6.034 6.493 6.897 7.134 7.427 7.886 8.568 9.027 9.264 9.477 9.714 10.173 10.386 10.79 11.027 11.486 11.945 12.182 12.641 12.878 13.337 13.796 14.009 14.468 14.927 15.14 15.544 16.003 16.462 16.755 16.992 17.674 18.133 18.346 18.583 19.042 19.255 19.492 19.729 20.188 20.647 20.94 21.399 21.803 22.04 22.499 22.958 23.171 23.63 24.089 24.302 24.706 25.165 25.458 25.917 26.321 26.78 27.017 27.476 28.158 28.395 28.854 29.313 29.717 29.954 30.167 30.571 31.03 31.243 31.702 32.161 32.62 32.833 33.292 33.696 33.989 34.448 34.852 35.065 35.469 35.928 36.387 36.6 36.837 37.074 37.533 37.992 38.285 38.744 39.203 39.662 40.066 40.279 40.738 41.197 41.49 41.703 41.94 42.399 42.612 43.071 43.308 43.767 44.226 44.685 45.144 45.381 45.84 46.053 46.457 46.916 47.375" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- En el feocromocitoma, la clonidina no suprime la liberación de catecolaminas, ya que estas son liberadas por la glándula supr</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 494.198113 349.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.459 0.752 1.045 1.504" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">arre-</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 73.701005 338.838599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.459 0.918 1.155" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">nal.</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 56.6929 316.4521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.722 1 1.556 2.167 2.723 3.092 3.648" font-family="g_d0_f6" font-size="1px" fill="rgb(255,127,125)">Diabetes</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 294.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 294.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.061 1.505 1.949 2.227 2.671 3.338 3.782 4.004 4.393 4.615 4.837 5.281 5.503 5.892 6.336 6.558 6.947 7.391 7.835 8.224 8.668 9.112 9.556 9.778 10.222 10.666 10.944 11.166 11.61 12.054 12.498 12.72 13.164 13.386 13.664 14.108 14.386 14.83 15.219 15.441 15.885 16.329 16.551 16.995 17.439 17.661 17.883 18.327 18.549 18.938 19.382 19.771 20.049 20.493 20.882 21.104 21.548 21.992 22.214 22.603 22.936 23.38 23.602 24.046 24.435 24.824 25.046 25.49 25.934 26.156 26.6 27.044 27.266 27.488 27.932 28.154 28.376 28.82 29.209 29.653 29.875 30.097 30.541 30.985" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Síndrome clínico causado por una alteración en la secreción y/o acción de la insulina.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 283.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 283.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.284 1.728 2.117 2.339 2.783 3.227 3.671 3.893 4.337 4.559 4.837 5.281 5.559 6.003 6.392 6.614 7.058 7.502 7.946 8.335 8.557 8.779 9.446 9.89 10.334 10.612 10.89 11.334 11.778 12.056 12.5 12.889 13.111 13.555 13.999 14.221 14.665 14.887 15.109 15.776 16.22 16.498 16.942 17.386 17.83 18.052 18.274 18.663 19.33 19.774 19.996 20.44 20.884 21.106 21.328 21.772 22.161 22.383 22.827 23.105 23.549 23.827 24.271 24.493 24.937 25.381 25.77 25.992 26.214 26.436 26.658 27.102 27.324 27.768 28.212 28.601 28.823 29.212 29.434 29.823 30.267 30.545 30.989 31.433 31.877 32.099 32.543 32.821 33.265 33.543 33.987 34.376" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Ocasiona alteraciones importantes en el metabolismo de las proteínas, lípidos y carbohidratos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 272.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 272.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.561 1.783 2.227 2.671 3.115 3.393 3.615 4.059 4.281 4.67 5.114 5.781 6.225 6.447 6.669 7.058 7.502 7.891 8.113 8.557 9.001 9.445 9.834 10.056 10.445 10.889 11.278 11.667 12.111 12.333 12.777 13.055 13.499 13.888 14.11 14.332 14.999 15.443 15.832 16.11 16.554 16.776 17.165 17.387 18.054 18.276 18.665 18.943 19.387 19.831 20.275 20.719 20.941 21.385 21.829 22.273 22.551 22.773 23.217 23.606 23.828 24.05 24.439 24.661 25.105 25.549 25.993 26.271 26.715 26.937 27.381 27.825 28.047 28.436 28.88 29.269 29.491 29.713 30.157 30.601 31.045 31.323 31.767 32.211 32.655 32.933 33.155 33.599 33.988 34.21" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Da lugar a complicaciones vasculares (macro y microangiopatías) y neurológicas (neuropatías).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 261.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 261.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.172 1.394 1.838 2.282 2.726 2.948 3.392 3.836 4.058 4.28 4.724 5.113 5.335 5.779 6.057 6.279 6.723 7.112 7.334 7.778 8.222 8.444 8.888 9.277 9.499 9.888 10.332 10.776 11.165 11.609 11.998 12.22 12.664 13.108 13.33 13.552 13.996 14.385 14.829 15.051 15.273 15.717 16.161 16.494 16.716 17.105 17.327 17.994 18.438 18.716 18.994 19.438 19.66 19.882 20.326 20.77 21.214 21.436 21.88 22.158 22.602 23.269 23.713 23.991 24.435 24.713 25.157 25.379 25.823 26.267 26.489 26.711 27.155 27.544 27.766 28.21 28.654 28.876 29.265 29.709 30.098 30.32 30.764 31.208 31.597 32.041 32.319 32.597 33.041 33.263 33.485 33.929 34.373 34.817 35.206" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Es una de las principales causas de invalidez y mortalidad prematura en los países desarrollados.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 250.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 250.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.172 1.394 1.783 2.061 2.505 2.949 3.171 3.449 3.727 4.171 4.56 4.782 5.06 5.504 5.893 6.337 6.726 6.948 7.392 7.781 8.225 8.447 8.891 9.169 9.391 9.78 10.224 10.613 10.835 11.279 11.723 11.945 12.389 12.611 12.833 13.277 13.721 14.11 14.554 14.832 15.11 15.554 15.776 15.998 16.442 16.664 17.108 17.552 17.774 17.996 18.44 18.662 19.106 19.328 19.772 20.216 20.66 20.938 21.382 21.771" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Existen tres fases evolutivas en el desarrollo de la diabetes:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 239.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2 2.278 2.722 3.166 3.61 3.832 4.276 4.665 4.887 5.331 5.775 5.997 6.441 6.885 7.163 7.83 8.274 8.496 8.718 9.162 9.606 9.828 10.05 10.494 10.716 11.16 11.382 11.826 12.215 12.659 13.048 13.492" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- La regulación normal de la glucosa.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 228.8385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2 2.444 2.666 2.944 3.388 3.666 4.11 4.499 4.721 5.165 5.609 5.831 6.275 6.719 6.941 7.163 7.607 7.829 8.273 8.495 8.939 9.328 9.772 10.161 10.605 10.827 11.271 11.715 11.937 12.381 12.77 13.214 13.658 14.102 14.491 14.713 15.157 15.379 15.601 16.045 16.323 16.767 16.989 17.433 17.711 18.155 18.599 18.988 19.21 19.654 19.876 20.32 20.542 20.764 21.208 21.43 21.874 22.096 22.54 22.929 23.373 23.762 24.206" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- La alteración de la glucosa en ayunas o intolerancia a la glucosa.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 217.8387) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2 2.444 2.666 3.11 3.554 3.998 4.276 4.72 5.109 5.331 5.998 6.442 6.664 6.886 7.108 7.386 7.83 8.219 8.441 8.663 9.219 9.997 10.219" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- La diabetes mellitus (DM).</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 195.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 195.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.733 0.955 1.399 1.843 2.232 2.454 2.898 3.342 3.564 4.008 4.23 4.674 5.118 5.562 5.84 6.284 6.673" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Tipos de diabetes:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 184.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.723 2.167 2.611 3.055 3.333 3.777 4.166 4.388 4.666 4.888 5.332 5.776 5.998 6.442" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Diabetes tipo 1.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 173.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.723 2.167 2.611 3.055 3.333 3.777 4.166 4.388 4.666 4.888 5.332 5.776 5.998 6.442" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Diabetes tipo 2.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 162.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.5009 1.7229 2.1669 2.6109 3.0549 3.3329 3.7769 4.1659 4.3878 4.8318 5.2758 5.6648 5.9428 6.3868 6.7758 6.9978 7.4418 7.8858 8.3298 8.5518" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Diabetes gestacional.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 151.8388) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.779 2.057 2.501 2.89 3.112 3.39 3.612 4.056 4.5 4.889 5.111 5.555 5.944 6.388 6.832 7.221 7.443 7.665 7.887 8.276 8.72 9.109 9.331 9.775 10.219 10.441 10.885 11.107 11.551 11.995 12.439 12.717 13.161 13.55 13.772" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">- Otros tipos especíﬁ cos de diabetes. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 129.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.722 1 1.556 2.167 2.723 3.056 3.612 4.112 4.39 4.723 5.001 5.612 6.223 6.501" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">Diabetes tipo 1</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 107.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 107.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 1.172 1.45 2.117 2.561 2.783 3.45 3.894 4.283 4.505 4.949 5.227 5.671 6.06 6.504 6.726 7.115 7.337 8.004 8.448 8.892 9.336 9.725 9.947 10.336 10.78 11.447 11.891 12.335 12.557 13.001 13.445 13.667 13.889 14.333 14.555 15.111 15.889 16.111 16.555 16.833 17.055 17.722 18.166 18.444 18.666 19.11" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Forma más grave y menos común de la DM primaria.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 96.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 96.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.783 2.061 2.505 2.894 3.338 3.56 4.004 4.448 4.726 4.948 5.17 5.614 5.836 6.28 6.724 7.113 7.391 7.669 8.113 8.502 8.891 9.113 9.557 10.001 10.223 10.667 11.111 11.333 11.555 11.999 12.388 12.61 12.999 13.443 13.665 14.109 14.331 14.775 15.164 15.386 15.83 16.274 16.552 16.996 17.218 17.662 18.106 18.328 18.55 18.994 19.438 19.882 20.271 20.549 20.993 21.437 21.826" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Aparece por la destrucción de las células beta del páncreas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.505 1.949 2.227 2.671 3.115 3.559 3.948 4.392 4.614 5.281 5.725 6.114 6.336 6.78 7.224 7.613 8.057 8.279 8.501 8.945 9.334 9.778 10 10.222 10.666 11.11 11.332 11.776 11.998 12.442 12.886 13.33 13.774" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Se produce muy poca insulina o nada.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.505 1.783 2.227 2.449 2.893 3.282 3.504 3.948 4.392 4.836 5.058 5.502 5.946 6.168 6.39 6.834 7.056 7.723 8.167 8.556 9 9.278 9.5 9.944 10.166 10.61 11.054 11.276 11.498 11.942 12.331 12.553 12.942 13.386 13.775 14.219 14.608 14.83 15.219 15.663 16.107 16.329 16.773 17.051 17.495 17.884 18.328 18.717 19.161 19.55 19.772 20.216 20.66 20.938 21.382 21.604 22.048 22.715 23.159 23.603 23.825 24.103 24.547 24.825 25.047 25.491 25.713 26.102 26.324 26.713 27.157 27.601 27.823 28.045 28.489 28.711 29.155 29.599 29.877 30.321 30.765 31.154 31.376 31.82 32.042 32.486 32.93 33.374 33.818 34.096 34.318 34.707 35.151" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)"> Se relaciona en la mayoría de las veces con procesos autoinmunitario y con la herencia genética.</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>